Cataract Induction and NLRP3 Inhibition
Corresponding Organization :
Other organizations : Tohoku University, Southern Medical University, Nanfang Hospital, South China University of Technology, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Chinese University of Hong Kong
Variable analysis
- Soluble UA (U2625, Sigma-Aldrich) at increasing doses (200 to 1000 μM)
- 400 μM MCC950 (CSN18163, CSNpharm, Chicago, USA), a selective NLRP3 antagonist
- Lens opacity
- NLRP3/caspase-1/IL-1β signaling
- Lens culture conditions (37 °C, 5% CO2)
- Culture medium (M-199 medium with 5% fetal bovine serum and antibiotics)
- Positive control: Lenses treated with increasing doses of soluble UA to induce cataract formation
- Negative control: Lenses treated with 400 μM MCC950, a selective NLRP3 antagonist
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!